SK63998A3 - Quinoline derivatives, method for the preparation thereof, pharmaceutical composition containing same, and their use - Google Patents
Quinoline derivatives, method for the preparation thereof, pharmaceutical composition containing same, and their use Download PDFInfo
- Publication number
- SK63998A3 SK63998A3 SK639-98A SK63998A SK63998A3 SK 63998 A3 SK63998 A3 SK 63998A3 SK 63998 A SK63998 A SK 63998A SK 63998 A3 SK63998 A3 SK 63998A3
- Authority
- SK
- Slovakia
- Prior art keywords
- benzo
- methyl
- quinoline
- thiadiazolyl
- triazolyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9523267.4A GB9523267D0 (en) | 1995-11-14 | 1995-11-14 | Organic compounds |
| PCT/EP1996/004978 WO1997018208A1 (fr) | 1995-11-14 | 1996-11-13 | Derives quinolines en tant qu'inhibiteurs des phosphodiesterases de type iv |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK63998A3 true SK63998A3 (en) | 1998-10-07 |
Family
ID=10783856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK639-98A SK63998A3 (en) | 1995-11-14 | 1996-11-13 | Quinoline derivatives, method for the preparation thereof, pharmaceutical composition containing same, and their use |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0873338A1 (fr) |
| JP (1) | JPH11515000A (fr) |
| KR (1) | KR19990067574A (fr) |
| CN (1) | CN1202170A (fr) |
| AU (1) | AU7570996A (fr) |
| BR (1) | BR9611504A (fr) |
| CA (1) | CA2235126A1 (fr) |
| CO (1) | CO4770973A1 (fr) |
| CZ (1) | CZ149498A3 (fr) |
| GB (1) | GB9523267D0 (fr) |
| HU (1) | HUP9903492A3 (fr) |
| MX (1) | MX9803839A (fr) |
| PE (1) | PE17598A1 (fr) |
| PL (1) | PL326636A1 (fr) |
| SK (1) | SK63998A3 (fr) |
| TR (1) | TR199800851T2 (fr) |
| WO (1) | WO1997018208A1 (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100701904B1 (ko) | 1999-08-21 | 2007-04-02 | 알타나 파마 아게 | Ｐｄｅ 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합 |
| CN1520313A (zh) | 2001-05-23 | 2004-08-11 | ������ҩ��ʽ���� | 一种加速骨折愈合的组合物 |
| CA2447618A1 (fr) | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | Composition pour le traitement regeneratif de la maladie du cartilage |
| TW200536851A (en) * | 2004-01-23 | 2005-11-16 | Amgen Inc | Compounds and methods of use |
| JP2006347936A (ja) * | 2005-06-15 | 2006-12-28 | Bayer Cropscience Ag | 殺虫性ベンズアニリド類 |
| AR081377A1 (es) | 2010-05-10 | 2012-08-29 | Gilead Sciences Inc | Compuestos de pirazolopiridina bifuncionales |
| EP2569285A1 (fr) | 2010-05-10 | 2013-03-20 | Gilead Sciences, Inc. | Dérivés quinoliniques bifonctionnels |
| AR093017A1 (es) | 2012-10-16 | 2015-05-13 | Janssen Pharmaceutica Nv | MODULARES DE RORgT DE QUINOLINILO UNIDOS POR METILENO |
| JP6250686B2 (ja) | 2012-10-16 | 2017-12-20 | ヤンセン ファーマシューティカ エヌ．ベー． | Ｒｏｒγｔのヘテロアリール結合させたキノリニルモジュレータ |
| JP6251277B2 (ja) | 2012-10-16 | 2017-12-20 | ヤンセン ファーマシューティカ エヌ．ベー． | ＲＯＲ−ガンマ−ｔのフェニル結合キノリニルモジュレーター |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| ES2770727T3 (es) | 2013-10-15 | 2020-07-02 | Janssen Pharmaceutica Nv | Moduladores de quinilonila enlazados a alquilo de ROR(gamma)t |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| US9624225B2 (en) | 2013-10-15 | 2017-04-18 | Janssen Pharmaceutica Nv | Quinolinyl modulators of RORγt |
| EP3813532B1 (fr) * | 2018-06-24 | 2024-02-28 | Adama Agan Ltd. | Procédé de préparation de quinmérac |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9027055D0 (en) * | 1990-12-13 | 1991-02-06 | Sandoz Ltd | Organic compounds |
| US5455252A (en) * | 1993-03-31 | 1995-10-03 | Syntex (U.S.A.) Inc. | Optionally substituted 6,8-quinolines |
-
1995
- 1995-11-14 GB GBGB9523267.4A patent/GB9523267D0/en active Pending
-
1996
- 1996-11-12 PE PE1996000810A patent/PE17598A1/es not_active Application Discontinuation
- 1996-11-13 CO CO96059775A patent/CO4770973A1/es unknown
- 1996-11-13 SK SK639-98A patent/SK63998A3/sk unknown
- 1996-11-13 BR BR9611504A patent/BR9611504A/pt not_active Application Discontinuation
- 1996-11-13 AU AU75709/96A patent/AU7570996A/en not_active Abandoned
- 1996-11-13 WO PCT/EP1996/004978 patent/WO1997018208A1/fr not_active Application Discontinuation
- 1996-11-13 CZ CZ981494A patent/CZ149498A3/cs unknown
- 1996-11-13 EP EP96938196A patent/EP0873338A1/fr not_active Withdrawn
- 1996-11-13 KR KR1019980703597A patent/KR19990067574A/ko not_active Application Discontinuation
- 1996-11-13 CN CN96198305A patent/CN1202170A/zh active Pending
- 1996-11-13 PL PL96326636A patent/PL326636A1/xx unknown
- 1996-11-13 CA CA002235126A patent/CA2235126A1/fr not_active Abandoned
- 1996-11-13 HU HU9903492A patent/HUP9903492A3/hu unknown
- 1996-11-13 JP JP9515313A patent/JPH11515000A/ja not_active Withdrawn
- 1996-11-13 TR TR1998/00851T patent/TR199800851T2/xx unknown
-
1998
- 1998-05-14 MX MX9803839A patent/MX9803839A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9803839A (es) | 1998-09-30 |
| KR19990067574A (ko) | 1999-08-25 |
| CZ149498A3 (cs) | 1998-08-12 |
| CA2235126A1 (fr) | 1997-05-22 |
| GB9523267D0 (en) | 1996-01-17 |
| WO1997018208A1 (fr) | 1997-05-22 |
| AU7570996A (en) | 1997-06-05 |
| CO4770973A1 (es) | 1999-04-30 |
| HUP9903492A3 (en) | 2000-08-28 |
| PL326636A1 (en) | 1998-10-12 |
| EP0873338A1 (fr) | 1998-10-28 |
| CN1202170A (zh) | 1998-12-16 |
| PE17598A1 (es) | 1998-04-06 |
| TR199800851T2 (xx) | 1998-08-21 |
| JPH11515000A (ja) | 1999-12-21 |
| BR9611504A (pt) | 1999-03-02 |
| HUP9903492A2 (en) | 2000-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK63998A3 (en) | Quinoline derivatives, method for the preparation thereof, pharmaceutical composition containing same, and their use | |
| US5177085A (en) | Dihydro-isoquinoline derivatives, processes for their production, pharmaceutical compositions containing them, and their use in treating asthma | |
| US5747506A (en) | Isoquinoline compounds, compositions containing them and their pharmaceutical uses | |
| US6136821A (en) | Naphthyridine derivatives | |
| KR100484045B1 (ko) | 기관지 치료용 벤조나프티리딘 | |
| US4980359A (en) | Isoquinoline derivatives and their use | |
| KR20070043968A (ko) | Ｐａｒｐ 저해제로서의 치환 ２-알킬 퀴나졸리논 유도체 | |
| WO2002036599A1 (fr) | Thieno[2,3-c]isoquinolines utilises en tant qu'inhibiteurs de parp | |
| JP2007506740A (ja) | イソキノリノンカリウムチャネル阻害剤 | |
| JP2006506414A (ja) | 抗炎症性３−アリールチオ−３−チアゾリル−アルキルアミン | |
| EP1142881A1 (fr) | Inhibiteurs de poly(adp-ribose) polymerase consistant en des derives de pyrimidine | |
| SU1395140A3 (ru) | Способ получени карбостирильных производных | |
| WO2005030771A1 (fr) | Derives imidazopyridine servant d'inhibiteurs de no-synthase inductible | |
| JP2007507463A (ja) | 誘導性ＮＯシンターゼ阻害剤としてのイミダゾ［４，５−ｂ］ピリジン誘導体 | |
| US11180475B2 (en) | Crystal form I of a 5-aminopyrazole carboxamide compound as BTK inhibitor | |
| NO178430B (no) | Nye dihydroisokinolinderivater og deres anvendelse som terapeutikum |